Dapagliflozin for depression study
Treatments studied
Part of Mental health clinical trials.
This trial tests whether dapagliflozin, a diabetes medication, can help treat major depression. It is for adults who have been depressed for at least 2 months and score high on a depression scale.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been feeling depressed for at least 2 months.
- Your depression symptoms are severe (score above 18 on the Hamilton depression scale).
- If you can become pregnant, you have a negative pregnancy test and use effective birth control.
- You do not have bipolar disorder, a personality disorder, or an eating disorder.
- You are not currently dependent on or abusing substances.
- You do not have a history of seizures, recent electroconvulsive therapy (ECT), or an inflammatory disorder.
- You are not allergic to dapagliflozin or similar medications.
- You are not pregnant or breastfeeding.
- You do not have diabetes or severe kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
This trial tests whether a medication called dapagliflozin can help improve anemia in people with chronic kidney disease. If you have moderate to severe kidney disease and low red blood cell counts despite taking standard anemia treatment, this study may explore a new option.
This study tests whether adding empagliflozin, a medication that helps control blood sugar, to your current bipolar depression treatment can improve depressive symptoms. It may help if you have insulin resistance, a condition where your body doesn't use insulin well.
This trial studies dapagliflozin, a diabetes medicine, to see if it can help people with paroxysmal atrial fibrillation (irregular heart rhythm). If you have both diabetes and this type of AF, the study may offer a chance to improve your heart rhythm and outcomes.
This trial tests whether a diabetes drug called dapagliflozin (also used for heart failure) can help people recover better after a recent heart attack. It's for adults who are already on standard blood thinners and have had a heart attack in the past week.
This trial tests whether a diabetes medicine called dapagliflozin can help improve anemia (low red blood cell count) in people with lower-risk myelodysplastic syndromes. Myelodysplastic syndromes are a group of blood disorders where the bone marrow doesn't make enough healthy blood cells. The study aims to see if this drug can help you feel better by boosting your blood counts.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.